Patent ID: 7829277

Claim:
A method for identifying a test compound that has the property of suppressing chemically-induced carcinogenesis in mammalian cells, the method comprising: a) providing RWPE-1 and RWPE-2 cells, b) measuring expression of a set of genes in the RWPE-1 and the RWPE-2 cells wherein the set of genes comprises at least the genes: ADAM9, BUB1B, CD46, GJA1, HIF1A, ITGB1, LAMB1, MAD2L1, the gene encoding FLJ20372, Formin binding protein 3, PSMC6, RANBP2, CSPG6, SP3, THBS1, TTK, PRKAR1A, TOB1, and Acidic leucine-rich nuclear phosphoprotein 32 family, member E, c) exposing RWPE-1 and RWPE-2 cells to the test compound, d) re-measuring the expression of the genes by the cells after exposure to the test compound, and e) comparing the expression of the genes in RWPE-1 cells with the expression of the genes in RWPE-2 cells, wherein a coordinated increase in expression of at least two-fold of all of the above genes in RWPE-1 cells but not in RWPE-2 cells following exposure to the test compound indicates that the test compound has the property of suppressing chemically-induced carcinogenesis in mammalian cells.